Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients

Authors

  • Christel C. L. M. Boons Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands; ;Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
  • Vashti N. M. F. Tromp Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands; ;Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
  • Nienke J. M. Neppelenbroek Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
  • Lonneke Timmers Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands; ;Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
  • Natasja M. van Schoor Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health research institute, Amsterdam, Netherlands
  • Eleonora L. Swart Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
  • N. Harry Hendrikse Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands; ;Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
  • Jeroen J. W. M. Janssen Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
  • Jacqueline G. Hugtenburg Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands; ;Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

DOI:

https://doi.org/10.1080/0284186X.2019.1585944

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2019-06-03

How to Cite

Boons, C. C. L. M. ., Tromp, V. N. M. F. ., Neppelenbroek, N. J. M. ., Timmers, L. ., van Schoor, N. M. ., Swart, E. L. ., … Hugtenburg, J. G. . (2019). Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients. Acta Oncologica, 58(6), 891–896. https://doi.org/10.1080/0284186X.2019.1585944

Issue

Vol. 58 No. 6 (2019): Acta Oncologica

Section

Articles